Why the study?
What is the role of echocardiography in diagnosing and monitoring drug-induced valvular heart disease?
What is the role of echocardiography in diagnosing and monitoring drug-induced valvular heart disease?
Answers are grounded in this paper and cite their sources.
This review provides a comprehensive overview of drug-induced valvular heart disease and practical recommendations for echocardiographic monitoring of patients on valvulopathic drugs.
The notion that drugs can induce valvular heart disease (VHD) has occurred since the 1960s and has received a lot of attention in recent years. This review focuses on different aspects of this distinct valvulopathy in seven sections: (i) historical background, (ii) drug-induced VHD, is this a real entity?, (iii) its morphological and echocardiographic features, (iv) drugs associated with VHD, (v) the influence of cumulative drug dose and risk factors, (vi) the natural course of toxic valvulopathy, and (vii) practical recommendations when using potential valvulopathic drugs.
No takes yet. Share an insight, caveat, or question.
Droogmans et al. (2009) conducted a review in Drug-induced valvular heart disease. Valvulopathic drugs was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: